Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery: a Parallel-group, Open-label, Randomised Controlled Trial.
This clinical trial investigates the efficacy and safety of Roxadustat in reducing perioperative blood transfusions in patients with anemia undergoing elective lumbar interbody fusion surgery. The study aims to provide insights into the potential market for Roxadustat in surgical settings, particularly for patients with anemia, which is a significant concern in surgical outcomes.
Indication: Perioperative Anemia
Modality: small molecule
Target: Perioperative Anemia
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Source URL: ClinicalTrials.gov
Source updated: Jan 13, 2025
Ingested: May 30, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Perioperative Anemia
View original source fields
Condition raw: Perioperative Anemia
Condition normalized: Perioperative Anemia
Modality raw: Perioperative Anemia
Modality normalized: small molecule
Target raw: Perioperative Anemia
Target normalized: Perioperative Anemia